Patent №
US 9,750,878
Granted
2017-09-05
Filed 2013
Owner
MEDTRONIC MINIMED, INC.
Lab
—
AI components
1
kr
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
14103522
Presented here are techniques for controlling glucose levels of a patient based on predicted time to a target glucose level. One methodology predicts a trajectory of the blood glucose level based on past observations of the blood glucose level, determines a cost expression based on the trajectory, and affects a future command to an infusion pump to affect a cost value according to the cost expression. Another methodology defines a target blood glucose concentration level for the patient, observes a current blood glucose concentration for the patient based on signals received from a blood-glucose sensor, and predicts a duration of time for the patient's blood glucose concentration to reach the target blood glucose concentration level based on the observed current blood glucose concentration.
AI classification
Ownership
MEDTRONIC MINIMED, INC.
assignment · 317620607
Assignors
ROY, ANIRBAN, KEENAN, DESMOND BARRY, KOVELMAN, PAUL H.
On an employer assignment, the assignors are typically the inventors.